| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer
1 company
Merendino Lauren serves as a Chief Commercial Officer at DAWN. Across recent SEC filings that breaks down to 0 buys and 3 sells. Those positions are worth an estimated $453K at current prices.
Historically, Merendino Lauren's trades have earned a below-average insider score of 26/100 across 3 rated trades. On a 3-month view, 0.0% of the rated trades came out ahead, averaging -21.4% over three months.
The biggest single holding is DAWN (~$453K) as Chief Commercial Officer. The recent filings there lean toward selling, a net 11,419 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2025 | DAWN Day One Biopharmaceuticals, Inc. | Chief Commercial Officer | Sale+OE | 3,726 | $8.91 | $33,216.17 | -6.8% | +34.4% | - | |
| Aug 18, 2025 | DAWN Day One Biopharmaceuticals, Inc. | Chief Commercial Officer | Sale+OE | 3,766 | $6.77 | $25,484.90 | -8.2% | +29.8% | - | |
| May 16, 2025 | DAWN Day One Biopharmaceuticals, Inc. | Chief Commercial Officer | Sale+OE | 3,927 | $6.26 | $24,574.77 | -10.0% | 0.0% | - |